STAA
STAAR Surgical CoNasdaqResearch view
Healthcare · Ophthalmic Goods · Small-cap · SEC EDGAR FY 2026-01-02
Price history
Chart: TradingView’s own feed · page prices: 1D EOD🔒 Click to interact · scroll moves the page
Snapshot
SEC EDGAR · FY 2026-01-02SectorHealthcare
Market Cap$1.0B
Enterprise Value$890.8M
Income$-80.4M
Sales$239.4M
Book/sh$6.86
Cash/sh$3.05
Dividend TTM—
Payout—
Employees—
IPO—
Quick Ratio4.32
Current Ratio4.55
Debt/Eq—
EPS (ttm)$-1.62
EPS this Y-295.1%
EPS past 3/5Y—
Sales past 3/5Y0.0%
EPS Y/Y TTM-295.1%
Sales Y/Y TTM-23.7%
Shs Outstand50.14M
ROA-17.8%
ROE-23.4%
ROIC-47.0%
Gross Margin76.2%
Oper. Margin-38.3%
Profit Margin-33.6%
Every figure here is filed with the SEC. Valuation and estimate metrics (P/E, PEG, EV/EBITDA, price targets, forward EPS) are omitted until our market-data feed is licensed for display — we’d rather show fewer numbers than blank ones. Deeper lines (cash flow, balance sheet) below.
Revenue & Earnings — fiscal year
$230.5M
2021
$239.4M
2022
$322.4M
2023
$313.9M
2024
$239.4M
2026
Financials — annual
SEC EDGAR · last 5 FY · tap a row to explain it| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2026 |
|---|---|---|---|---|---|
| Revenue | $230.5M | $239.4M | $322.4M | $313.9M | $239.4M |
| Gross Profit | $178.6M | $223.4M | $252.7M | $239.6M | $182.4M |
| Operating Income | $33.3M | $43.8M | $28.1M | $-12.6M | $-91.7M |
| Net Income | $27.5M | $39.7M | $21.3M | $-20.2M | $-80.4M |
| Diluted EPS | $0.56 | $0.80 | $0.43 | $-0.41 | $-1.62 |
| Operating Cash Flow | $44.0M | $35.7M | $14.6M | $15.7M | $-34.2M |
| Free Cash Flow | $30.3M | $17.6M | $-3.6M | $-7.7M | $-40.0M |
Deep dive
Computed from the SEC EDGAR multi-year statementsOperating leverage — margins
GrossOperatingNet
FY26 cash-flow waterfall
Cash-flow detail unavailable in this filing.
—
COMMUNITY · $STAA0 theses
POST YOUR TAKE →Related Stocks
Click to exploreSame Industry · Ophthalmic Goods
Fundamentals sourced from SEC EDGAR filings (public domain). For informational purposes only. Not investment advice.